Périodique
Marijuana and medicine: assessing the science base. A summary of the 1999 Institute of Medicine report
(Marijuana et médecine : évaluer les bases scientifiques. Un résumé du rapport 1999 de l'institut de Médecine)
Auteur(s) :
WATSON, S. J. ;
BENSON, J. A. ;
JOY J. E.
Année
2000
Page(s) :
547-552
Langue(s) :
Français
Refs biblio. :
23
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
CANNABIS
;
USAGE THERAPEUTIQUE
;
EVALUATION
;
EFFET SECONDAIRE
;
SEVRAGE
;
TOLERANCE
Note générale :
Archives of General Psychiatry, 2000, 57, (6), 547-552
Résumé :
ENGLISH :
In response to public pressure to allow the medical use of marijuana, the Office of National Drug Control Policy, Washington, DC, funded a study by the Institute of Medicine evaluating the scientific evidence for benefits and risks of using marijuana as a medicine. The report used scientific reviews, public hearings, and reports from other agencies, and was evaluated by knowledgeable advisors and reviewers. It called for heavier investment in research on the biology of cannabinoid systems, careful clinical studies of cannabinoids in clinical syndromes, analysis of cannabinoids' psychological effects on symptoms, and evaluations of the health consequences of heavy marijuana use; recommends against the use of smoked marijuana in medicine and for the development of a medical cannabinoid inhaler; and recommends that compassionate use of marijuana be considered under carefully reviewed protocols. Finally, the report evaluates the abuse potential, tolerance, withdrawal, and gateway risks of medical use of cannabinoid drugs. (Review' s abstract)
Affiliation :
Dpt of Psychiatry, Mental Health Research Institute, Univ. of Michigan, Ann Arbor
Etats-Unis. United States.
Etats-Unis. United States.
Cote :
A00689
Historique